AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vriglim-M 3 Tablet PR

Prescription Icon
Prescription Required

Marketer

Vridam Healthcare Pvt Ltd

Salt Composition

Glimepiride (3mg) + Metformin (500mg)

Overview Vriglim-M 3 Tablet PR

DiabetaComb 3 tablets are anti-diabetic medications combining two drugs to manage type 2 diabetes in adults. They help regulate blood glucose. DiabetaComb 3 should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking this medication even if you feel well; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication is part of a comprehensive diabetes management plan, encompassing a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect, characterized by sweating, dizziness, headaches, and tremors. Learn to recognize and manage hypoglycemia; consistent meals and readily available glucose sources (e.g., sugary foods, fruit juice) are crucial. Alcohol increases hypoglycemia risk and should be limited. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver disease. Inform your doctor of any heart history before starting this medication; it may be unsuitable. Pregnant or breastfeeding individuals should consult their physician. Regular blood glucose monitoring and periodic blood tests (blood counts, liver function) are necessary.

Uses of Vriglim-M 3 Tablet PR

Managing type 2 diabetes

Major Benefits of Vriglim-M 3 Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidance. Take Vriglim-M 3 Tablet PR with a meal.

Common Side effects of Vriglim-M 3 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Vriglim-M 3 Tablet PR:

Follow your doctor's instructions or refer to the package insert for proper administration. Take Vriglim-M 3 Tablet PR with meals.

How Vriglim-M 3 Tablet PR works:

Vriglim-M 3 Tablet PR combines glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin's action is threefold: it decreases hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining alcohol and Vriglim-M 3 Tablet PR is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vriglim-M 3 Tablet PR during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Vriglim-M 3 Tablet PR are incompatible. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vriglim-M 3 Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Physician consultation is recommended. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Exercise caution when administering Vriglim-M 3 Tablet PR to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. For patients exhibiting mild to moderate liver dysfunction, initiate Vriglim-M 3 Tablet PR therapy at a reduced dosage; its use is contraindicated in those with severe liver disease.

What if you forget to take Vriglim-M 3 Tablet PR :

Should you forget a Vriglim-M 3 Tablet PR dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.

Facts to Know About Vriglim-M 3 Tablet PR

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Management

FAQs on Vriglim-M 3 Tablet PR

Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Vriglim-M 3 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Vriglim-M 3 Tablet PR and seek immediate medical attention.
Vriglim-M 3 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Vriglim-M 3 Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged Vriglim-M 3 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Vriglim-M 3 Tablet PR can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Vriglim-M 3 Tablet PR with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Vriglim-M 3 Tablet PR
113
MRP 131
13% off